Search results
Earnings call: Biora Therapeutics reports progress on NaviCap and BioJet platforms By Investing.com
Investing.com· 24 hours agoBiora Therapeutics (NASDAQ:BIOR) has announced significant advancements in its NaviCap and BioJet...
Lumos Pharma Inc (LUMO) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ...
GuruFocus.com via Yahoo Finance· 16 hours agoResearch and development expenses increased by $2.9 million due to higher licensing and clinical trial expenses, adding financial pressure as the company progresses towards ...
Bio-Path Holdings Inc (BPTH) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...
GuruFocus.com via Yahoo Finance· 16 hours agoCompletion of the second dose cohort in the Phase 1/1B clinical trial of BP1002 for treating refractory relapsed AML, including venetoclax-resistant patients, showing no & ...
Biora Therapeutics Inc (BIOR) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...
GuruFocus.com via Yahoo Finance· 16 hours agoTotal Capital Raised: Over $31 million in the last four months. Release Date: May 15, 2024 For the complete transcript of the earnings call, please...patients. Biora Therapeutics ...
Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...
GuruFocus.com via Yahoo Finance· 16 hours agoNet Loss (Q1 2024): $37.2 million, or $0.63 per share. Net Loss (Q4 2023): $9.1 million, or $0.15 per share. Cash and Investments (As of March 31, 2024) ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 hours agoMP0533: Phase 1 trial continues to demonstrate acceptable safety and antitumor activity up to cohort 6, dosing in cohort 7 ongoing, additional dose escalation cohorts being ...
There might be stockpiles, but making an effective bird flu vaccine won’t be quick or easy
The Telegraph via Yahoo News· 2 days agoHealth officials have been steadfast in their assurances. The risk of H5N1 bird flu jumping into...
BioAtla Inc (BCAB) (Q1 2024) Earnings Call Transcript Highlights: Strategic Adjustments and ...
GuruFocus.com via Yahoo Finance· 2 days agoExpected Operating Cash Burn: Approximately $20 million for Q2 2024, with a decrease anticipated in the second half of the year. Funding Operations: Current...and an 86% disease ...
Panbela Therapeutics Inc (PBLA) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
GuruFocus.com via Yahoo Finance· 16 hours agoCash Used in Operations: Approximately $9.4 million in Q1 2024. Release Date: May 15, 2024 For the complete transcript of the earnings call, please...prevention, with data ...
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 8 hours agoZytiga sales declined 25.9% to $181.0 million in the quarter due to generic competition. Sales of...